ATE551353T1 - Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten - Google Patents

Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten

Info

Publication number
ATE551353T1
ATE551353T1 AT04725350T AT04725350T ATE551353T1 AT E551353 T1 ATE551353 T1 AT E551353T1 AT 04725350 T AT04725350 T AT 04725350T AT 04725350 T AT04725350 T AT 04725350T AT E551353 T1 ATE551353 T1 AT E551353T1
Authority
AT
Austria
Prior art keywords
protein
syncitin
fusogenic
activity similar
sequence
Prior art date
Application number
AT04725350T
Other languages
English (en)
Inventor
Thierry Heidmann
Marie Dewannieux
Sandra Blaise
Laurence Benit
Parseval Nathalie De
Vladimir Lazar
Marianne Mangeney
Original Assignee
Centre Nat Rech Scient
I N S E R M Inst Nat De La Sante Et De La Rech Medicale
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, I N S E R M Inst Nat De La Sante Et De La Rech Medicale, Roussy Inst Gustave filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE551353T1 publication Critical patent/ATE551353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT04725350T 2003-04-04 2004-04-02 Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten ATE551353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45997403P 2003-04-04 2003-04-04
PCT/EP2004/003552 WO2004087748A1 (en) 2003-04-04 2004-04-02 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same

Publications (1)

Publication Number Publication Date
ATE551353T1 true ATE551353T1 (de) 2012-04-15

Family

ID=33131908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04725350T ATE551353T1 (de) 2003-04-04 2004-04-02 Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten

Country Status (3)

Country Link
EP (1) EP1651667B1 (de)
AT (1) ATE551353T1 (de)
WO (1) WO2004087748A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1871391T3 (da) 2005-03-30 2012-04-16 Viroxis Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling
JP7037486B2 (ja) * 2015-10-01 2022-03-16 エイムヴィオン・アクティエセルスカブ 医薬としてのヒト由来免疫抑制タンパク質およびペプチドの使用
EP3235828A1 (de) * 2016-04-21 2017-10-25 Genethon Stabile pseudotypisierte lentivirale teilchen und verwendungen davon
CA3033262A1 (en) * 2016-08-23 2018-03-01 Aimvion A/S Novel immunostimulating peptides
CA3062426A1 (en) 2017-05-08 2018-11-15 Flagship Pioneering Innovations V, Inc. Compositions for facilitating membrane fusion and uses thereof
IL273923B2 (en) * 2017-10-20 2024-08-01 Genethon Using syncytin for drug targeting and gene delivery to lung tissue
CA3078096A1 (en) * 2017-10-20 2018-10-19 Genethon Use of syncytin for targeting drug and gene delivery to regenerating muscle tissue
AU2019343045A1 (en) 2018-09-18 2021-05-13 Vnv Newco Inc. ARC-based capsids and uses thereof
WO2020252455A1 (en) 2019-06-13 2020-12-17 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides
CA3189601A1 (en) 2020-07-24 2022-01-27 The General Hospital Corporation Enhanced virus-like particles and methods of use thereof for delivery to cells
US20260062455A1 (en) * 2022-03-04 2026-03-05 Institut Pasteur Uptake mechanism of essential lysophospholipids into the brain and inhibition by endogenous-retroviral envelope protein
CN118561966B (zh) * 2024-05-20 2025-07-11 浙江大学 人内源性逆转录病毒包膜蛋白突变体、截短体及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797889A1 (fr) 1999-09-01 2001-03-02 Bio Merieux Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides

Also Published As

Publication number Publication date
EP1651667B1 (de) 2012-03-28
EP1651667A1 (de) 2006-05-03
WO2004087748A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
EP4467650A3 (de) Gerüstproteine
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
PT1548032E (pt) Péptidos kdr e vacinas que os contêm
MX2009004147A (es) Vacunas de peptido para canceres que expresan polipeptidos mphosph1 o depdc1.
AR047347A1 (es) Miembros de la familia cry9 de bacillus
NZ602351A (en) Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
NZ600690A (en) Fkbp-l and uses thereof
MX2010002001A (es) Peptido cdca1 y agente farmaceutico que comprende elmismo.
WO2021248016A3 (en) Novel omni-59, 61, 67, 76, 79, 80, 81, and 82 crispr nucleases
MX2008009493A (es) Peptido novedoso y uso del mismo.
BR112022012057A2 (pt) Novos métodos de entrega celular
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DE60335726D1 (de) Chromoprotein und fluoroproteine
MX2009007261A (es) Vacuna de peptido foxp3.
MX2023011194A (es) Peptido y composicion que contiene peptido.
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
GB0010314D0 (en) Anti-freeze proteins their production and use
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
MX2011004176A (es) Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo.
MX2024004272A (es) Nueva proteina de polen de junipero.
WO2018200814A3 (en) Modified cyclic peptides and therapeutic use thereof
MY182816A (en) Cancer antigen peptide
MX2025009172A (es) Péptido derivado de gse24.2 y usos del mismo
MX2023007406A (es) Composiciones que comprenden ciclotidos y otros peptidos insecticidas y usos de las mismas.